The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Signals through T cell receptor-zeta chain alone are insufficient to prime resting T lymphocytes.
Open accessAbstract
Activation studies performed with transfected T cell hybridomas and tumors revealed that chimeric molecules containing the CD3 epsilon or zeta chain intracytoplasmic portions can induce the complete effector functions normally seen only when the complete T cell receptor (TCR)/CD3 complexes of T lymphocytes are triggered. Therefore, the zeta chain, with its three antigen recognition activation motives, is thought to connect the antigen-binding Ti chains with the intracellular signaling machinery of the T cell. Here we demonstrate that the cytoplasmic portion of the TCR-zeta chain is not sufficient to activate resting T lymphocytes when cells from transgenic mice expressing a chimeric zeta receptor are used. However, after (in vivo and in vitro) activation through their endogenous TCR/CD3 complexes, the preactivated T lymphocytes could be triggered through the zeta chimera to the same extent as when they were activated through their endogenous TCR/CD3 complexes. They were able to proliferate and elicit cytotoxic functions when triggered through their zeta chimeras. These results suggest that the triggering requirements for effector functions seem to be different in resting than in activated T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
T-cell antigen receptor genes and T-cell recognition
Davis, M. M., & Bjorkman, P. J. (1988) · Nature · doi:10.1038/334395a0 · Cited by 3,202
Signal transduction by lymphocyte antigen receptors
Weiss, A., & Littman, D. R. (1994) · Cell · doi:10.1016/0092-8674(94)90334-4 · Cited by 2,089
Identification of a monoclonal antibody specific for a murine T3 polypeptide.
Leo, O., Foo, M., Sachs, D. H., Samelson, L. E., & Bluestone, J. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1374 · Cited by 1,593
RETH, M. (1989) · Nature · doi:10.1038/338383b0 · Cited by 1,438
Cate, R. L., Mattaliano, R. J., Hession, C., Tizard, R., Farber, N. M., Cheung, A., Ninfa, E. G., Frey, A. Z., Gash, D. J., Chow, E. P., et al. (1986) · Cell · doi:10.1016/0092-8674(86)90783-x · Cited by 1,022
Irving, B. A., & Weiss, A. (1991) · Cell · doi:10.1016/0092-8674(91)90314-o · Cited by 805
The T Cell Receptor/Cd3 Complex: A Dynamic Protein Ensemble
Clevers, H. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.629 · Cited by 791
The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules
Wegener, A.-M. K., Letourneur, F., Hoeveler, A., Brocker, T., Luton, F., & Malissen, B. (1992) · Cell · doi:10.1016/0092-8674(92)90208-t · Cited by 431
Self-citationActivation of T Cells by a Tyrosine Kinase Activation Domain in the Cytoplasmic Tail of CD3 ε
Letourneur, F., & Klausner, R. D. (1992) · Science · doi:10.1126/science.1532456 · Cited by 426
Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides
Romeo, C., & Seed, B. (1991) · Cell · doi:10.1016/0092-8674(91)90327-u · Cited by 396
Greaves, D. R., Wilson, F. D., Lang, G., & Kioussis, D. (1989) · Cell · doi:10.1016/0092-8674(89)90631-4 · Cited by 357
Sequence requirements for induction of cytolysis by the T cell antigenFc receptor ζ chain
Romeo, C., Amiot, M., & Seed, B. (1992) · Cell · doi:10.1016/0092-8674(92)90032-8 · Cited by 324
T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor zeta family proteins.
Letourneur, F., & Klausner, R. D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.8905 · Cited by 307
Antigens displayed on murine B lymphocyte precursors.
Kincade, P. W., Lee, G., Watanabe, T., Sun, L., & Scheid, M. P. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.6.2262 · Cited by 289
Samelson, L. E., & Klausner, R. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)73981-7 · Cited by 274
Bonifacino, J. S., Cosson, P., & Klausner, R. D. (1990) · Cell · doi:10.1016/0092-8674(90)90447-m · Cited by 267
Orloff, D. G., Ra, C., Frank, S. J., Klausner, R. D., & Kinet, J.-P. (1990) · Nature · doi:10.1038/347189a0 · Cited by 241
Down-regulation of homing receptors after T cell activation.
Jung, T. M., Gallatin, W. M., Weissman, I. L., & Dailey, M. O. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.12.4110 · Cited by 234
Gold, D. P., Puck, J. M., Pettey, C. L., et al. (1986) · Nature · doi:10.1038/321431a0 · Cited by 157
New simplified molecular design for functional T cell receptor
Brocker, T., Peter, A., Traunecker, A., & Karjalainen, K. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230705 · Cited by 84
Self-citation
Cited by
CAR-T cell therapy: current limitations and potential strategies
Sterner, R. C., & Sterner, R. M. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00459-7 · Cited by 2,926
Chimeric Antigen Receptor Therapy
June, C. H., & Sadelain, M. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1706169 · Cited by 2,331
The Basic Principles of Chimeric Antigen Receptor Design
Sadelain, M., Brentjens, R., & Rivière, I. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0548 · Cited by 1,535
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Rafiq, S., Hackett, C. S., & Brentjens, R. J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0297-y · Cited by 1,472
Therapeutic T cell engineering
Sadelain, M., Rivière, I., & Riddell, S. (2017) · Nature · doi:10.1038/nature22395 · Cited by 879
Metadata
- Authors
- Brocker, T., & Karjalainen, K.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1995-05-01
- Volume
- 181
- Issue
- 5
- Pages
- 1653-1659
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2166487857
- Cited by
- 296
- References
- 20
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.